Xenon Pharmaceuticals (XENE) Enterprise Value Growth (3y) (2016 - 2026)
Xenon Pharmaceuticals (XENE) Enterprise Value Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Xenon Pharmaceuticals | 5.71 Bn | 5.71 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -27.59% |
| Dec 31, 2025 | -16.48% |
| Sep 30, 2025 | -12.68% |
| Jun 30, 2025 | -7.42% |
| Mar 31, 2025 | -0.72% |
| Dec 31, 2024 | -4.35% |
| Sep 30, 2024 | -37.86% |
| Jun 30, 2024 | -40.43% |
| Mar 31, 2024 | -36.56% |
| Dec 31, 2023 | -53.33% |
| Sep 30, 2023 | -40.25% |
| Jun 30, 2023 | -38.58% |
| Mar 31, 2023 | -31.90% |
| Dec 31, 2022 | -61.20% |
| Sep 30, 2022 | -88.95% |
| Jun 30, 2022 | -97.83% |
| Mar 31, 2022 | -69.52% |
| Dec 31, 2021 | -66.61% |
| Sep 30, 2021 | -25.22% |
| Jun 30, 2021 | -60.28% |